Wednesday 17 June, 2026
Welcome to the home of pharma innovation
Building on the success of the Pharma and Life Sciences Summit at HLTH Europe 2025, the exclusive one day global pharma summit gives senior industry leaders the opportunity to step out of operational cycles and address head-on the forces that will define the industry’s next decade.
It offers a strategic view of how scientific progress, regulatory shifts, competition, and market dynamics shape decisions that drive pipeline strength and commercial performance.
Join 250+ senior leaders to inform your decisions, make the right connections, and surface real opportunities.
For life science leaders
For solution providers
Pharma attendees include:
Who's coming?
We’re convening the key players of life sciences - C-suite leaders from pharma and biotech, top regulators, and senior innovators - for an exclusive, behind-closed-doors gathering.
Pharma and life sciences leaders
C-suite and senior executives from global pharma and leading life sciences companies who steer portfolio strategy, investment decisions, and long-term enterprise direction.
Commercial, medical, and market access leaders
Senior leaders responsible for shaping product strategy across the lifecycle, from generating evidence and engaging scientific communities to navigating pricing, access, and the commercial execution required for successful global launches.
Policy makers and regulatory authorities
Influential voices shaping the policy and regulatory frameworks that govern how innovation advances from early development to approval, access, and adoption.
Innovators and strategic partners
Senior leaders and innovators from technology, AI, investment, who bring new approaches and partnership models that accelerate life sciences innovation.
Pharma Summit snapshot
10+
sponsors backing the Summit
30+
countries across every major European market
40+
leading pharma organisations
250+
senior attendees shaping global strategy
1 in 2
C-suite
Why attend?
Strategic insight
Understand how shifts in science, policy, markets, and technology are shaping pharma’s next decade.
Partnership opportunities
Explore collaborations with senior leaders across pharma, policy, technology, and investment in a focused, high-level environment.
Innovation in practice
See how new approaches in AI, evidence generation, and clinical development are influencing decisions from discovery to commercialisation.
High-value networking
Build meaningful connections with decision-makers who influence portfolio direction, policy, market access, and enterprise strategy.
"HLTH Europe is the ONE event everyone in healthcare should attend."
Lu Zheng
VP, Head of Digital Health
Takeda Pharmaceuticals
Themes shaping the 2026 programme
Future of R&D and clinical development
Regulatory science and evolving policy
Commercial innovation and launch excellence
Digital transformation and AI in pharma’s core business
Global access, pricing, and market dynamics
